| __timestamp | Exelixis, Inc. | Merck & Co., Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 25111000 | 42237000000 |
| Thursday, January 1, 2015 | 37172000 | 39498000000 |
| Friday, January 1, 2016 | 191454000 | 39807000000 |
| Sunday, January 1, 2017 | 452477000 | 40122000000 |
| Monday, January 1, 2018 | 853826000 | 42294000000 |
| Tuesday, January 1, 2019 | 967775000 | 46840000000 |
| Wednesday, January 1, 2020 | 987538000 | 41518000000 |
| Friday, January 1, 2021 | 1434970000 | 48704000000 |
| Saturday, January 1, 2022 | 1611062000 | 59283000000 |
| Sunday, January 1, 2023 | 1830208000 | 60115000000 |
| Monday, January 1, 2024 | 2168701000 |
Data in motion
In the competitive landscape of the pharmaceutical industry, revenue growth is a key indicator of success. Over the past decade, Merck & Co., Inc. and Exelixis, Inc. have shown contrasting trajectories. Merck, a giant in the industry, has consistently maintained a robust revenue stream, peaking at approximately $60 billion in 2023, marking a 42% increase from 2014. In contrast, Exelixis, a smaller biotech firm, has demonstrated impressive growth, with revenues skyrocketing by over 7,000% from 2014 to 2023, reaching nearly $1.8 billion. This stark difference highlights the dynamic nature of the industry, where established players and emerging companies both find their niches. As we look to the future, these trends underscore the importance of innovation and strategic positioning in sustaining growth.
Johnson & Johnson and Merck & Co., Inc.: A Comprehensive Revenue Analysis
Breaking Down Revenue Trends: Merck & Co., Inc. vs Teva Pharmaceutical Industries Limited
Comparing Revenue Performance: Merck & Co., Inc. or Halozyme Therapeutics, Inc.?
Cost of Revenue: Key Insights for Merck & Co., Inc. and Exelixis, Inc.
Merck & Co., Inc. and Exelixis, Inc.: A Detailed Gross Profit Analysis
Operational Costs Compared: SG&A Analysis of Merck & Co., Inc. and Exelixis, Inc.
Merck & Co., Inc. vs Dynavax Technologies Corporation: Examining Key Revenue Metrics
Merck & Co., Inc. vs Celldex Therapeutics, Inc.: Examining Key Revenue Metrics
Annual Revenue Comparison: Exelixis, Inc. vs Pharming Group N.V.
Who Generates More Revenue? Exelixis, Inc. or Cytokinetics, Incorporated
Exelixis, Inc. and Supernus Pharmaceuticals, Inc.: A Comprehensive Revenue Analysis
Breaking Down Revenue Trends: Exelixis, Inc. vs Taro Pharmaceutical Industries Ltd.